Relapse in patients with limited‐stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow‐up of a phase 2 study

BACKGROUND: Approximately 50% of limited‐stage ocular adnexal mucosa‐associated lymphoid tissue lymphoma (OAML) patients with adverse prognostic factors relapse after radiotherapy. Chemoimmunotherapy has been proposed as an alternative frontline therapy. However, only a few studies have reported its...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung‐Yong, Lee, Won‐Sik, Oh, Sung Yong, Yang, Deok‐Hwan, Kim, Hyo Jung, Park, Seong Kyu, Yang, Jae Wook, Yang, Suk‐Woo, Cho, Seok‐Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302339/
https://www.ncbi.nlm.nih.gov/pubmed/35277938
http://dx.doi.org/10.1002/cam4.4639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302339/
https://www.ncbi.nlm.nih.gov/pubmed/35277938
http://dx.doi.org/10.1002/cam4.4639

Ejemplares similares